All Stories

  1. Cardiovascular Complications of Down Syndrome: Scoping Review and Expert Consensus
  2. Rationale, design and methodology of APPROACH-IS II: International study of patient-reported outcomes and frailty phenotyping in adults with congenital heart disease
  3. Training to care for adults with congenital heart disease in the USA and Europe
  4. Twenty-year experience and outcomes in a National Pediatric Pulmonary Hypertension Service
  5. Physiology of the normal heart
  6. Use of Pulmonary Arterial Hypertension Therapies in Patients with a Fontan Circulation: Current Practice Across the United Kingdom
  7. Prognostic implications of pulmonary wave reflection and reservoir pressure in patients with pulmonary hypertension
  8. Cardiopulmonary exercise testing in congenital heart disease: towards serial testing as part of long-term follow-up
  9. Pulmonary arterial hypertension in adults with congenital heart disease: markers of disease severity, management of advanced heart failure and transplantation
  10. Systemic microangiopathy in Eisenmenger syndrome – The missing link?
  11. Safety of physical sports and exercise in ACHD
  12. Enhanced Assessment of Perioperative Mortality Risk in Adults With Congenital Heart Disease
  13. Ultra‐Fast‐Track Extubation in Adult Congenital Heart Surgery
  14. Preventing disease progression in Eisenmenger syndrome
  15. Integrating patient-reported outcome measures in congenital heart disease care
  16. Palliative care in pulmonary hypertension associated with congenital heart disease: systematic review and expert opinion
  17. Cardiac disease in Down Syndrome: literature review and international expert consensus in collaboration with Down Syndrome International (DSi)
  18. Non-cardiac surgery in congenital heart disease-associated pulmonary arterial hypertension: risk recognition and management
  19. PAH-CHD: transition to adulthood
  20. Often transferred, rarely transitioned: The current state of transition for young people with congenital heart disease
  21. Advanced therapies in Eisenmenger syndrome
  22. Pulmonary arterial hypertension associated with congenital heart disease after defect repair: the effect of pregnancy
  23. The investigation and diagnosis of pulmonary hypertension in adults with congenital heart disease
  24. Congenital Heart Disease and Pulmonary Hypertension
  25. Transcatheter Pulmonary Valve Prosthesis and Pregnancy
  26. Pulmonary artery denervation for pulmonary arterial hypertension
  27. Sex differences in hypertrophic cardiomyopathy: Time to tailor risk stratification and therapy?
  28. Congenital heart disease, pulmonary arterial hypertension and the UK’s Drivers and Vehicle Licensing Agency: controversial new guidance
  29. Modifiable risk factors in congenital heart disease: Education, transition, digital health and choice architecture
  30. Evaluating a strategy of PAH therapy pre-treatment in patients with atrial septal defects and pulmonary arterial hypertension to permit safe repair (“treat-and-repair”)
  31. The effects of parenteral prostacyclin therapy as add-on treatment to oral compounds in Eisenmenger syndrome
  32. Eisenmenger syndrome and other types of pulmonary arterial hypertension related to adult congenital heart disease
  33. CMR Right Ventricular-Pulmonary Arterial Coupling and Right Ventricular Trabecular Complexity: Prognostic in Lung Transplant Assessment?
  34. Heart or heart-lung transplantation for patients with congenital heart disease in England
  35. 32 The Impact of Haemoglobin Reduction on Short- and Long-Term Mortality Following Primary Percutaneous Coronary Intervention for St-Elevation Myocardial Infarction-analysis from a Real World Stemi Population
  36. Management of ST elevation myocardial infarction in pregnancy
  37. Non-electrolyte permeability of deoxygenated sickle cells compared